Menu

Ditch the Floss?

US government agencies can’t provide strong scientific evidence that flossing is beneficial.

Aug 3, 2016
Bob Grant

WIKIMEDIA, D. SHARON PRUITTAn investigation spearheaded by the Associated Press (AP) has turned up a woeful lack of evidence pointing to a tangible health benefit related to the US government’s recommendation that Americans floss every day for maximal dental health. “The evidence for flossing is ‘weak, very unreliable,’ of ‘very low’ quality, and carries ‘a moderate to large potential for bias,’” AP reporter Jeff Donn wrote in a story explaining the investigation, published this week (August 2).

The government has issued the flossing advice since 1979, in a Surgeon General’s report and in its Dietary Guidelines for Americans, which must be supported by scientific evidence. Professional dentistry associations and thousands of dentists throughout the country have made the same recommendation for decades. But last year, when the AP asked the US Department of Health and Human Services and the US Department of Agriculture to provide scientific evidence to support the recommendation, the agencies admitted that the benefits of flossing have never been adequately studied in rigorous scientific experiments. And when the government released the latest Dietary Guidelines for Americans this year, the flossing recommendation was conspicuously absent.

Studies that have looked at the health effects of flossing seem poorly designed, too small, or improperly conducted, the AP reported.

Representatives of the American Dental Association and the American Academy of Periodontology (AAP) acknowledged the weakness of published evidence pointing to flossing’s benefits, but they largely stuck to their existing advice. “It’s like building a house and not painting two sides of it,” AAP President Wayne Aldredge told the AP. “Ultimately those two sides are going to rot away quicker.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening